JP2008542220A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542220A5
JP2008542220A5 JP2008512759A JP2008512759A JP2008542220A5 JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5 JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5
Authority
JP
Japan
Prior art keywords
polymer
active substance
core
biologically active
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008512759A
Other languages
English (en)
Japanese (ja)
Other versions
JP5080453B2 (ja
JP2008542220A (ja
Filing date
Publication date
Priority claimed from EP05028165A external-priority patent/EP1726299A3/en
Application filed filed Critical
Publication of JP2008542220A publication Critical patent/JP2008542220A/ja
Publication of JP2008542220A5 publication Critical patent/JP2008542220A5/ja
Application granted granted Critical
Publication of JP5080453B2 publication Critical patent/JP5080453B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008512759A 2005-05-27 2006-05-24 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法 Expired - Fee Related JP5080453B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05011516 2005-05-27
EP05011516.1 2005-05-27
EP05028165.8 2005-12-22
EP05028165A EP1726299A3 (en) 2005-05-27 2005-12-22 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
PCT/EP2006/004940 WO2006125620A2 (en) 2005-05-27 2006-05-24 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Publications (3)

Publication Number Publication Date
JP2008542220A JP2008542220A (ja) 2008-11-27
JP2008542220A5 true JP2008542220A5 (enExample) 2009-07-02
JP5080453B2 JP5080453B2 (ja) 2012-11-21

Family

ID=36935013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512759A Expired - Fee Related JP5080453B2 (ja) 2005-05-27 2006-05-24 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法

Country Status (7)

Country Link
EP (2) EP1726299A3 (enExample)
JP (1) JP5080453B2 (enExample)
AT (1) ATE424190T1 (enExample)
CA (1) CA2609891A1 (enExample)
DE (1) DE602006005491D1 (enExample)
DK (1) DK1906928T3 (enExample)
WO (1) WO2006125620A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
BRPI0811777A2 (pt) 2007-05-23 2019-09-24 Allergan Inc partículas de ácido hialurõnico revestidas
EP2152743A2 (en) 2007-05-23 2010-02-17 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en) 2008-09-02 2010-03-11 Gurtner Geoffrey C Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
EP2544652A2 (en) 2010-03-12 2013-01-16 Allergan Industrie SAS A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
EP3520827B1 (en) 2010-03-22 2022-05-25 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9149422B2 (en) 2011-06-03 2015-10-06 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
WO2016128550A1 (en) 2015-02-13 2016-08-18 Allergan Industrie, Sas Implants for sculpting, augmenting or correcting facial features such as the chin
WO2025137151A2 (en) 2023-12-18 2025-06-26 The Johns Hopkins University Dendrimer compositions for the treatment of atherosclerosis, obesity, and metabolic syndromes
CN118146569B (zh) * 2024-01-24 2024-11-22 中国海洋大学 透明质酸-青蒿琥酯-聚精氨酸纳米粒、制备方法及应用
WO2025265116A1 (en) 2024-06-21 2025-12-26 Georgia State University Research Foundation, Inc. Nanobodies to henipavirus and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
EP0576675A4 (en) * 1991-03-25 1994-06-01 Fujisawa Pharmaceutical Co Long-acting pharmaceutical preparation
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
SE505146C2 (sv) 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
CA2296620A1 (en) * 1997-07-18 1999-01-28 Kris P. Antonsen Methods of removing residual solvent from nasal drug delivery compositions
SE9903236D0 (sv) 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
ES2315244T3 (es) * 1999-11-12 2009-04-01 Fibrogen, Inc. Gelatina recombinante en vacunas.
CA2424931A1 (en) 2000-10-06 2002-04-11 Jagotec Ag Starch
AU2001294458B2 (en) 2000-10-06 2004-03-11 Jagotec Ag Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
ATE409465T1 (de) * 2000-10-06 2008-10-15 Pacira Pharmaceuticals Inc Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzung

Similar Documents

Publication Publication Date Title
JP2008542220A5 (enExample)
Rao et al. Synthesis and Characterization of biodegradable Poly (Vinyl caprolactam) grafted on to sodium alginate and its microgels for controlled release studies of an anticancer drug
Tu et al. Alginate microparticles prepared by spray–coagulation method: Preparation, drug loading and release characterization
US9220689B2 (en) Nanoparticles
Li et al. Functionalization of halloysite nanotubes by enlargement and hydrophobicity for sustained release of analgesic
Liu et al. Fabrication of degradable polymer microspheres via pH-responsive chitosan-based Pickering emulsion photopolymerization
CN105494430A (zh) 一种载银低分子量壳聚糖复合微球抗菌剂及其制备方法
JP2009542795A5 (enExample)
CN114276681B (zh) 多级介孔结构的聚多巴胺微球及其制备方法
CN109293976B (zh) 一种多孔壳聚糖微球的制备方法
CN100532438C (zh) 一种淀粉微球及其制备方法
CN102658072A (zh) 单分散壳聚糖中空微球的制备方法
JP2005511335A5 (enExample)
CN101225179A (zh) 一种大面积有序多孔膜材料及其制备方法
de Matos Fonseca et al. Chitosan microparticles embedded with multi-responsive poly (N-vinylcaprolactam-co-itaconic acid-co-ethylene-glycol dimethacrylate)-based hydrogel nanoparticles as a new carrier for delivery of hydrophobic drugs
CN105037802B (zh) 一种二氧化硅包覆硫磺微胶囊的制备方法
CN110698718B (zh) 纳米羟基磷灰石包覆的中空聚合物微球及其制备方法和应用
He et al. Cagelike polymer microspheres with hollow core/porous shell structures
CN104127386B (zh) 一种大叶茜草素/壳聚糖纳米微球及其制备方法和应用
Tan et al. Preparation, characterization, and drug‐release properties of PEG‐DA‐based copolymer hydrogel microspheres
CN101564668A (zh) 微胶囊的制备方法
CN106822917B (zh) 丙烯酸酯功能化的桥键介孔载体材料及其制备方法
CN102631951B (zh) 一种制备具有高效催化性能的有机无机杂化纳米二氧化钛空心球的方法
CN105131157A (zh) 一种云母钛原位填充的聚苯乙烯银灰色保温材料的制备方法、其产品及应用
Dong et al. General fabrication of hollow colloids from polymer self-assembly cavity-forming strategy